Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acetonitrile compound. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113214112A reveals a mild, base-catalyzed route for beta-amino acrylate substituted acetonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110240554A enables high-purity α-sulfide aryl acetonitrile synthesis with mild conditions, reducing manufacturing costs and ensuring supply chain continuity for pharmaceutical intermediates.
Solve nitrile synthesis challenges with this novel metal-free route. Achieve 78% yield, no toxic byproducts, and scalable production for anti-inflammatory drug development.